Literature DB >> 1804024

Susceptibility of anaerobic bacteria isolated from intra-abdominal infections to ofloxacin and interaction of ofloxacin with metronidazole.

E J Goldstein1, D M Citron.   

Abstract

The in vitro activities of ofloxacin alone and in combination with metronidazole against 177 anaerobic bacteria isolated from intra-abdominal infections, as determined by broth microdilution, showed that some Bacteroides fragilis strains were susceptible and that most other B. fragilis group species strains were resistant to ofloxacin. Isolates of other anaerobic species and genera, including those causing female genital tract disease, were generally susceptible to ofloxacin. Ofloxacin in combination with metronidazole usually showed an additive or indifferent interaction but no antagonism.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1804024      PMCID: PMC245404          DOI: 10.1128/AAC.35.11.2447

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  10 in total

1.  Ofloxacin versus vancomycin/polymyxin for prevention of infections in granulocytopenic patients.

Authors:  D J Winston; W G Ho; D A Bruckner; R P Gale; R E Champlin
Journal:  Am J Med       Date:  1990-01       Impact factor: 4.965

2.  The comparative in-vitro activity of ofloxacin.

Authors:  R N Grüneberg; D Felmingham; M D O'Hare; M J Robbins; K Perry; R A Wall; G L Ridgway
Journal:  J Antimicrob Chemother       Date:  1988-09       Impact factor: 5.790

3.  Gut decontamination by oral ofloxacin and ciprofloxacin in healthy volunteers.

Authors:  H K van Saene; S E Lemmens; J J van Saene
Journal:  J Antimicrob Chemother       Date:  1988-09       Impact factor: 5.790

4.  Pharmacokinetics of ofloxacin and the effect on the faecal flora of healthy volunteers.

Authors:  D A Leigh; B Walsh; K Harris; P Hancock; G Travers
Journal:  J Antimicrob Chemother       Date:  1988-09       Impact factor: 5.790

5.  Interactions of ciprofloxacin with clindamycin, metronidazole, cefoxitin, cefotaxime, and mezlocillin against gram-positive and gram-negative anaerobic bacteria.

Authors:  J L Whiting; N Cheng; A W Chow
Journal:  Antimicrob Agents Chemother       Date:  1987-09       Impact factor: 5.191

6.  Effect of inoculum size on in vitro activity of norfloxacin against fecal anaerobic bacteria. Rationale for selective decontamination of the digestive tract.

Authors:  E J Goldstein; D M Citron; M L Corrado
Journal:  Am J Med       Date:  1987-06-26       Impact factor: 4.965

Review 7.  Ofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  J P Monk; D M Campoli-Richards
Journal:  Drugs       Date:  1987-04       Impact factor: 9.546

8.  The in-vitro activities of enoxacin and ofloxacin compared with that of ciprofloxacin.

Authors:  A King; K Shannon; I Phillips
Journal:  J Antimicrob Chemother       Date:  1985-05       Impact factor: 5.790

Review 9.  In vitro antimicrobial activity and susceptibility testing of ofloxacin. Current status.

Authors:  P C Fuchs
Journal:  Am J Med       Date:  1989-12-29       Impact factor: 4.965

10.  Norfloxacin binds to human fecal material.

Authors:  C Edlund; L Lindqvist; C E Nord
Journal:  Antimicrob Agents Chemother       Date:  1988-12       Impact factor: 5.191

  10 in total
  5 in total

Review 1.  Quinolone activity against anaerobes.

Authors:  P C Appelbaum
Journal:  Drugs       Date:  1999       Impact factor: 9.546

Review 2.  Synergy and antagonism of fluoroquinolones with other classes of antimicrobial agents.

Authors:  H C Neu
Journal:  Drugs       Date:  1993       Impact factor: 9.546

Review 3.  Quinolone activity against anaerobes: microbiological aspects.

Authors:  P C Appelbaum
Journal:  Drugs       Date:  1995       Impact factor: 9.546

4.  In vivo efficacies of quinolones and clindamycin for treatment of infections with Bacteroides fragilis and/or Escherichia coli in mice: correlation with in vitro susceptibilities.

Authors:  I Brook
Journal:  Antimicrob Agents Chemother       Date:  1993-05       Impact factor: 5.191

5.  Comparative antimicrobial efficacy of Metapex, Metronidazole, BioPure MTAD, Aztreonam on Bacteroides fragilis and Propionibacterium acne.

Authors:  Rajkumar Balakrishnan; Sandeep Dubey; Tapan Kumar N Dhole; Lalit C Boruah; Sanjeev Srivastava
Journal:  J Conserv Dent       Date:  2013-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.